INTRODUCTION {#s1}
============

Globally, primary liver carcinoma (PLC) is the fifth most common malignant tumor, resulting in 600,000 deaths each year \[[@R1]\]. Intrahepatic cholangiocarcinoma (ICC) is a carcinoma arising from the epithelial cells of the intrahepatic bile duct branches of the second-order or beyond. Although ICC is rare in clinical practice, its incidence and mortality rates have increased gradually in the past 30 years \[[@R2]-[@R7]\]. The incidence of ICC accounts for 10% of all cholangiocarcinomas and 3% of gastrointestinal carcinomas \[[@R8], [@R9]\].

ICC is caused by a variety of etiologies, such as hepatitis B, hepatitis C, AIDS, intrahepatic bile duct stones, liver cirrhosis, primary sclerosing cholangitis, parasitic infections, chemical carcinogens, obesity, type II diabetes, and nonalcoholic fatty liver disease \[[@R10]\]. With the continuous improvement of the quality of life in China, the incidences of excessive alcohol consumption, obesity, type II diabetes, and nonalcoholic fatty liver disease have increased. As early as 2006, the number of patients with chronic hepatitis B in China had reached 20 million \[[@R11]\]. The abovementioned factors may be responsible for the world's highest incidence of ICC being reported in Asia, including in China \[[@R12]\]. The median survival time in ICC patients is as low as 2-6 months if only palliative treatment is involved. Moreover, the survival time is over 5 years in less than 10% of patients, regardless of the treatment regimen \[[@R3], [@R13], [@R14]\]. However, the 5-year survival rate after surgical resection ranges from 30-35% \[[@R15]\]. Although hepatectomy is the main treatment method for early ICC, only approximately one-third of ICC patients have an opportunity to undergo resection. The median survival time is only approximately 3 years, and the recurrence rate is as high as 50-60%; at the time of ICC diagnosis, the majority of patients are in the late stage and missed their opportunity to receive radical resection \[[@R16]\]. A high grade of malignancy, lower radical resection rate, and poor prognosis have resulted in a tremendous effect on ICC patients; therefore, this topic is worth further study.

With an increase in its aging population, China now has a high incidence of ICC, which deserves our full attention. Therefore, this retrospective cohort study was designed to determine the prognostic factors that can affect postoperative disease-free survival (DFS) and overall survival (OS) according to survival data and clinicopathological characteristics in the follow-up of 319 patients who underwent radical resection of ICC. This study aims to provide references for the clinical diagnosis and treatment of ICC.

MATERIALS AND METHODS {#s2}
=====================

General data {#s2_1}
------------

This single-center, retrospective cohort study was approved by the ethical committee of the Shanghai Eastern Hepatobiliary Surgery Hospital. The study protocol conformed to the principles of the Declaration of Helsinki. The study subjects were selected from 319 patients who underwent radical resection (R0) of ICC from October 1999 to December 2003 in our hospital. Of these patients, 225 were male and 94 were female. Their average age was 52.70 ± 10.50 years (range: 22-81 years). A total of 109 patients (76 males and 33 females with a mean age of 53.44 ± 11.24 years) were included in the group with OS ≤ 1 year. The remaining 210 patients (149 males and 61 females with a mean age of 52.31 ± 10.10 years) were included in the group with OS \> 1 year. The balance test showed that there were no significant differences (P \> 0.05) in sex or age between the two groups. Thus, the data were compatible. All of the patients were diagnosed with ICC, and their diagnosis was confirmed by pathological examination. Patients with mixed HCC were excluded.

Study methods {#s2_2}
-------------

### Clinical data collection {#s2_2_1}

The clinical data of the patients were collected, including gender, age, tumor number, number of liver segments with tumors, perioperative blood transfusion, postoperative pathological type, the presence of liver cirrhosis, maximum tumor diameter, complicated bile duct stone, serum CA199 levels, macroscopic tumor thrombus, and tumor staging. According to their morphology, ICC can be graded as well, moderately and poorly differentiated adenocarcinoma. Well-differentiated ICCs include tubular adenocarcinoma with/without micropapillary structures; moderately differentiated ICCs include moderately distorted tubular glands with cribriform formations and/or a cord-like pattern; and poorly differentiated ICCs include distorted tubular or cord-like structures with marked cellular pleomorphism (WHO classification of tumors of the digestive system) Complicated bile duct stones were defined as the presence of calculi within the intrahepatic biliary tree proximal to the confluence of the left and right hepatic ducts. Tumor staging in all of the patients was determined according to the UICC TNM classification of malignant tumors, 7th edition.

### Definition of radical resection {#s2_2_2}

Radical hepatectomy primarily includes regular hepatectomy and hemihepatectomy, irregular hepatectomy, extended hepatectomy, and concomitant removal of bile duct stone or regional lymphadenectomy. The following criteria should be met: (1) all tumors are removed without residual tumor; (2) negative margins are confirmed by histological examination; (3) there is no major vascular invasion; and (4) preoperative elevated CA199 levels return to normal within 2 months after surgery. The preoperative assessment of liver function was based on the Child-Pugh scoring system. The surgical method and resection region were determined according to the tumor size and distribution and the hepatic functional reserve. Whether extended hepatectomy was performed was based on an evaluation of the volume of the remaining liver based on the results of a preoperative computed tomography (CT) scan or magnetic resonance imaging (MRI). The clamp crushing and finger fracture methods were used for anatomical liver resection at room temperature, with intermittent use of Pringle's maneuver. The distance between the tumor and cut edge was 1-1.5 cm. The detection of regional lymph node metastases was based on CT/MRI/PET-CT. If regional lymph node metastases are suspected, regional lymphadenectomy should be considered, including complete excision of soft tissue and lymph nodes at the hepatic hilum, common hepatic artery, hepatoduodenal ligament, portal vein and posterior to the pancreatic head stations. A definitive diagnosis was made by pathologic evidence.

### Follow-up {#s2_2_3}

Follow-up was performed in all of the patients by telephone communication or outpatient visits. The observed outcomes included DFS and OS. The initial event to assess DFS was radical hepatectomy, and the endpoint was the time of tumor recurrence or the occurrence of a censored event. The initial event to assess OS was radical hepatectomy, and the endpoint event was the death of the patient or the occurrence of a censored event. Censored events included the following: (1) loss of patients during follow-up; and (2) no evidence of tumor recurrence or the patient was still alive at the end of the follow-up. Recurrence was diagnosed based on imaging of B-mode ultrasound, CT scan, and MRI, or on confirmation of ICC recurrence by biopsy and pathological examinations. The starting time of follow-up was the time point when radical hepatectomy was performed, and the endpoint was May 15, 2016. Loss of follow-up was defined as the occurrence of the following events: the patient had missed their outpatient visits for 6 months; the patient could not be reached by phone; or the patient was not hospitalized for 6 months. In this study, 118 cases were lost during the follow-up, and 201 cases completed the follow-up. The follow-up rate was 63.01% (201/319). The follow-up duration ranged between 1 and 177 months, with a median follow-up duration of 13 months.

### Statistical analysis {#s2_2_4}

The statistical analysis was performed with SPSS 17.0 software. The chi-square test was used for the count data, and the rank sum test was used for the ranked data. A multivariate analysis for shorter OS was performed using a binary logistic regression. The survival rate was calculated using the Kaplan-Meier method. The survival rates were compared using the log-rank method. A Cox regression model was used to analyze the prognostic factors. A P value of less than 0.05 was considered statistically significant.

RESULTS {#s3}
=======

Clinicopathological characteristics of the 319 patients who underwent radical resection of ICC {#s3_1}
----------------------------------------------------------------------------------------------

Of the 319 ICC patients, 225 patients were male, and 94 patients were female, with an average age of 52.70 ± 10.50 years (range: 22-81 years). A statistical description of the clinicopathological characteristics for these patients is shown in Table [1](#T1){ref-type="table"}.

###### Clinicopathological characteristics of 319 patients who underwent radical resection of ICC

                                    Number of cases   Total number of cases   Percentage (%)
  --------------------------------- ----------------- ----------------------- ----------------
  Gender                                              319                     
  male                              225                                       70.5
  female                            94                                        29.5
  Age                                                 319                     
  \> 55 years                       126                                       39.5
  ≤ 55 years                        193                                       60.5
  Single tumor                                        319                     
  yes                               229                                       71.8
  no                                90                                        28.2
  Tumor distribution                                  319                     
  \> 2 hepatic segments             116                                       36.4
  ≤ 2 hepatic segments              203                                       63.6
  Perioperative blood transfusion                     319                     
  yes                               137                                       42.9
  no                                182                                       57.1
  Pathological type                                   291                     
  Well differentiated               4                                         1.4
  Moderately differentiated         113                                       38.8
  Poorly differentiated             174                                       59.8
  Evidence of liver cirrhosis                         319                     
  yes                               123                                       61.4
  no                                196                                       38.6
  Maximum tumor diameter (cm)                         319                     
  ≤5                                127                                       39.8
  \>5, ≤10                          139                                       43.6
  \>10                              53                                        16.6
  Complicated bile duct stone                         318                     
  yes                               30                                        9.4
  no                                288                                       90.6
  Serum CA199 (U/ml)                                  313                     
  \>37                              174                                       55.6
  ≤37                               139                                       44.4
  Macroscopic tumor thrombus                          319                     
  yes                               39                                        12.2
  no                                280                                       87.8
  Pathology T                                         319                     
  T1                                10                                        3.1
  T2                                130                                       40.8
  T3                                86                                        27
  T4                                93                                        29.2
  Pathology N                                         319                     
  N0                                293                                       91.8
  N1                                26                                        8.2
  Pathology M                                         319                     
  M0                                316                                       99.1
  M1                                3                                         0.9
  Pathology stage                                     319                     
  I                                 10                                        3.1
  II                                119                                       37.3
  III                               97                                        30.4
  IV                                93                                        29.2

Analysis of the impact factor for DFS after radical resection {#s3_2}
-------------------------------------------------------------

The univariate Cox analysis showed that the number of tumors, tumor distribution, perioperative blood transfusion, maximum tumor diameter, complicated bile duct stone, serum CA199 levels (U/ml), macroscopic tumor thrombus, Pathology T, Pathology N, and pathology stage were the prognostic factors that affected the DFS in patients who underwent radical hepatectomy for ICC (*P* \< 0.05). The significant prognostic factors determined by the univariate analysis were included in a multivariate Cox analysis, which showed that maximum tumor diameter (HR = 1.330, *P* = 0.014), complicated bile duct stone (HR = 1.923, *P* = 0.013), macroscopic tumor thrombus (HR = 1.826, *P* = 0.009), and Pathology N (HR = 2.330, *P* = 0.005) were independent adverse prognostic factors that affected the DFS of patients who underwent radical hepatectomy for ICC (Table [2](#T2){ref-type="table"}). The median DFS was 6 months; the DFS curves are shown in Figure [1A](#F1){ref-type="fig"}.

###### Analysis of impact on DFS after radical resection

  Clinicopathological characteristics   Number of cases   Univariate analysis   Multivariate analysis                                    
  ------------------------------------- ----------------- --------------------- ----------------------- ---------------- ------- ------- ----------------
  Gender                                                  0.917                 0.576                   (0.676, 1.244)                   
  male                                  225                                                                                              
  female                                94                                                                                               
  Age                                                     1.264                 0.106                   (0.951, 1.680)                   
  \> 55 years                           126                                                                                              
  ≤ 55 years                            193                                                                                              
  Single tumor                                            1.621                 0.002                   (1.193, 2.202)   1.022   0.948   (0.538, 1.940)
  yes                                   229                                                                                              
  no                                    90                                                                                               
  Tumor distribution                                      1.222                 0.002                   (1.079, 1.348)   1.511   0.226   (0.775, 2.945)
  \> 2 hepatic segments                 116                                                                                              
  ≤ 2 hepatic segments                  203                                                                                              
  Perioperative blood transfusion                         1.410                 0.019                   (1.059, 1.877)   0.998   0.993   (0.698, 1.427)
  yes                                   137                                                                                              
  no                                    182                                                                                              
  Pathological type                                       1.082                 0.593                   (0.810, 1.445)                   
  Well differentiated                   4                                                                                                
  Moderately differentiated             113                                                                                              
  Poorly differentiated                 174                                                                                              
  Evidence of liver cirrhosis                             0.913                 0.535                   (0.683, 1.219)                   
  yes                                   123                                                                                              
  no                                    196                                                                                              
  Maximum tumor diameter (cm)                             1.447                 0.000                   (1.189, 1.761)   1.330   0.014   (1.060, 1.669)
  ≤5                                    127                                                                                              
  \>5, ≤10                              139                                                                                              
  \>10                                  53                                                                                               
  Complicated bile duct stone                             1.718                 0.020                   (1.089, 2.708)   1.923   0.013   (1.145, 3.227)
  yes                                   30                                                                                               
  no                                    288                                                                                              
  Serum CA199 (U/ml)                                      1.456                 0.011                   (1.089, 1.946)   1.266   0.486   (0.652, 2.457)
  \>37                                  174                                                                                              
  ≤37                                   139                                                                                              
  Macroscopic tumor thrombus                              1.739                 0.009                   (1.146, 2.637)   1.826   0.009   (1.160, 2.873)
  yes                                   39                                                                                               
  no                                    280                                                                                              
  Pathology T                                             1.363                 0.000                   (1.158, 1.604)   1.727   0.091   (0.917, 3.251)
  T1                                    10                                                                                               
  T2                                    130                                                                                              
  T3                                    86                                                                                               
  T4                                    93                                                                                               
  Pathology N                                             2.156                 0.005                   (1.261, 3.686)   2.330   0.005   (1.297, 4.186)
  N0                                    293                                                                                              
  N1                                    26                                                                                               
  Pathology M                                             1.245                 0.759                   (0.308, 5.028)                   
  M0                                    316                                                                                              
  M1                                    3                                                                                                
  Pathology stage                                         1.383                 0.000                   (1.172, 1.630)   0.986   0.972   (0.434, 2.239)
  I                                     10                                                                                               
  II                                    119                                                                                              
  III                                   97                                                                                               
  IV                                    93                                                                                               

![**A.** DFS curves; **B.** OS curves.](oncotarget-08-75627-g001){#F1}

Impact factor analysis of OS after radical resection {#s3_3}
----------------------------------------------------

The univariate Cox analysis showed that the tumor distribution, maximum tumor diameter, complicated bile duct stone, serum CA199 level (U/ml), Pathology T, Pathology N, and pathology stage were the prognostic factors for OS in patients who underwent radical hepatectomy for ICC (*P* \< 0.05). The significant prognostic factors determined by the univariate analysis were included in the multivariate Cox analysis, which showed that the maximum tumor diameter (HR = 1.326, *P* = 0.014), complicated bile duct stone (HR = 2.349, *P* = 0.001), and Pathology N (HR = 2.420, *P* = 0.003) were independent adverse prognostic factors that affected OS of patients who underwent radical hepatectomy for ICC (Table [3](#T3){ref-type="table"}). The postoperative median survival time was 22 months; the 3-year survival rate was 33.9%; and the 5-year survival rate was 23.2%. The OS curves are shown in Figure [1B](#F1){ref-type="fig"}. The survival comparison by log-rank method of independent prognostic factors, such as maximum tumor diameter, complicated bile duct stone, and Pathology N, are shown in Figure [2](#F2){ref-type="fig"}.

###### Analysis of impact on OS after radical resection

  -------------------------------------------------------------------------------------------------------------------------------------------------------
  Clinicopathological characteristics   Number of cases   Univariate analysis   Multivariate analysis                                    
  ------------------------------------- ----------------- --------------------- ----------------------- ---------------- ------- ------- ----------------
  Gender                                                  0.915                 0.566                   (0.675, 1.240)                   

  male                                  225                                                                                              

  female                                94                                                                                               

  Age                                                     1.193                 0.229                   (0.895, 1.589)                   

  \> 55 years                           126                                                                                              

  ≤ 55 years                            193                                                                                              

  Single tumor                                            1.267                 0.132                   (0.932, 1.723)                   

  yes                                   229                                                                                              

  no                                    90                                                                                               

  Tumor distribution                                      1.710                 0.000                   (1.272, 2.299)   1.209   0.331   (0.825, 1.774)

  \> 2 hepatic segments                 116                                                                                              

  ≤ 2 hepatic segments                  203                                                                                              

  Perioperative blood transfusion                         1.274                 0.097                   (0.957, 1.697)                   

  yes                                   137                                                                                              

  no                                    182                                                                                              

  Pathological type                                       1.173                 0.272                   (0.882, 1.560)                   

  Well differentiated                   4                                                                                                

  Moderately differentiated             113                                                                                              

  Poorly differentiated                 174                                                                                              

  Evidence of liver cirrhosis                             0.888                 0.424                   (0.662, 1.189)                   

  yes                                   123                                                                                              

  no                                    196                                                                                              

  Maximum tumor diameter (cm)                             1.451                 0.000                   (1.190, 1.770)   1.326   0.014   (1.059, 1.660)

  ≤5                                    127                                                                                              

  \>5, ≤10                              139                                                                                              

  \>10                                  53                                                                                               

  Complicated bile duct stone                             1.874                 0.007                   (1.187, 2.960)   2.349   0.001   (1.397, 3.950)

  yes                                   30                                                                                               

  no                                    288                                                                                              

  Serum CA199 (U/ml)                                      1.494                 0.007                   (1.115, 2.001)   1.178   0.309   (0.859, 1.617)

  \>37                                  174                                                                                              

  ≤37                                   139                                                                                              

  Macroscopic tumor thrombus                              1.422                 0.109                   (0.925, 2.187)                   

  yes                                   39                                                                                               

  no                                    280                                                                                              

  Pathology T                                             1.272                 0.004                   (1.080, 1.498)   0.636   1.248   (0.499, 3.125)

  T1                                    10                                                                                               

  T2                                    130                                                                                              

  T3                                    86                                                                                               

  T4                                    93                                                                                               

  Pathology N                                             2.578                 0.001                   (1.491, 4.458)   2.420   0.003   (1.340, 4.372)

  N1                                    26                                                                                               

  N0                                    293                                                                                              

  Pathology M                                             1.588                 0.516                   (0.393, 6.413)                   

  M0                                    316                                                                                              

  M1                                    3                                                                                                

  Pathology stage                                         1.299                 0.002                   (1.101,\         0.912   0.949   (0.375, 2.398)
                                                                                                        1.532)                           

  I                                     10                                                                                               

  II                                    119                                                                                              

  III                                   97                                                                                               

  IV                                    93                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------

![The survival comparison of independent prognostic factors using the log-rank method: maximum tumor diameter\
**A.**, complicated bile duct stone **B.**, and lymph node metastasis (Pathology N1) **C.**.](oncotarget-08-75627-g002){#F2}

Risk factor analysis for shorter OS (OS ≤ 1 year) after radical resection {#s3_4}
-------------------------------------------------------------------------

We defined shorter OS as OS ≤ 1 year. A total of 109 patients (76 males and 33 females with a mean age of 53.44 ± 11.24 years) were included in the group with OS ≤ 1 year. The remaining 210 patients (149 males and 61 females with a mean age of 52.31 ± 10.10 years) were included in the group with OS \> 1 year. The balance test showed that there was no significant difference (P \> 0.05) in sex or age between the 2 groups. Thus, the data were compatible. The univariate analysis showed that the tumor number, tumor distribution, complicated bile duct stone, macroscopic tumor thrombus, and Pathology T may be relevant factors that result in a postoperative shorter OS (*P* \< 0.05). The binary logistic multivariate analysis showed that macroscopic tumor thrombus may be an independent risk factor for a shorter OS in ICC patients after radical resection (OR = 2.991, *P* = 0.004) (Table [4](#T4){ref-type="table"}).

###### Analysis of risk on shorter OS (OS ≤ 1 year) after radical resection

  Clinicopathological characteristics   Number of cases   Univariate analysis   Multivariate analysis                           
  ------------------------------------- ----------------- --------------------- ----------------------- ------- ------- ------- ----------------
  Gender                                                                                                0.820                   
  male                                  225               76                    149                                             
  female                                94                33                    61                                              
  Age                                                                                                   0.477                   
  \> 55 years                           126               46                    80                                              
  ≤ 55 years                            193               63                    130                                             
  Single tumor                                                                                          0.031   0.748   0.568   (0.275, 2.029)
  yes                                   229               70                    159                                             
  no                                    90                39                    51                                              
  Tumor distribution                                                                                    0.011   1.661   0.57    (0.986, 2.799)
  \> 2 hepatic segments                 116               50                    66                                              
  ≤ 2 hepatic segments                  203               59                    144                                             
  Perioperative blood transfusion                                                                       0.216                   
  yes                                   137               52                    85                                              
  no                                    182               57                    125                                             
  Pathological type                                                                                     0.160                   
  Well differentiated                   4                 1                     3                                               
  Moderately differentiated             113               32                    81                                              
  Poorly differentiated                 174               68                    106                                             
  Evidence of liver cirrhosis                                                                           0.995                   
  yes                                   123               42                    81                                              
  no                                    196               67                    129                                             
  Maximum tumor diameter (cm)                                                                           0.071                   
  ≤5                                    127               109                   210                                             
  \>5, ≤10                              139                                                                                     
  \>10                                  53                                                                                      
  Complicated bile duct stone                                                                           0.021   2.755   0.232   (1.149, 6.605)
  yes                                   30                16                    14                                              
  no                                    288               93                    195                                             
  Serum CA199 (U/ml)                                                                                    0.077                   
  \>37                                  174               68                    106                                             
  ≤37                                   139               41                    98                                              
  Macroscopic tumor thrombus                                                                            0.000   2.991   0.004   (1.429, 6.260)
  yes                                   39                23                    16                                              
  no                                    280               86                    194                                             
  Pathology T                                                                                           0.000   1.237   0.324   (0.810, 1.890)
  T1                                    10                109                   210                                             
  T2                                    130                                                                                     
  T3                                    86                                                                                      
  T4                                    93                                                                                      
  Pathology N                                                                                           0.362                   
  N0                                    293               109                   210                                             
  N1                                    26                                                                                      
  Pathology M                                                                                           0.211                   
  M0                                    316               109                   210                                             
  M1                                    3                                                                                       
  Pathology stage                                                                                       0.057                   
  I                                     10                109                   210                                             
  II                                    119                                                                                     
  III                                   97                                                                                      
  IV                                    93                                                                                      

DISCUSSION {#s4}
==========

The prognostic factors for survival in ICC patients have not been fully elucidated, and many factors and mechanisms remain under investigation. In this study, follow-up (duration: 1-177 months) for survival was performed in 319 patients who underwent radical hepatectomy of ICC between October 1999 and December 2003 in our hospital. The median follow-up duration was 13 months; 118 cases were lost during the follow-up. The possible prognostic factors related to ICC were analyzed, and the high risk factors for poor prognosis in ICC patients were investigated.

In this study, a multivariate Cox analysis showed that the maximum tumor diameter, complicated bile duct stone, and lymph node metastasis were independent adverse prognostic factors that affected the DFS and OS in ICC patients after radical hepatectomy. Macroscopic tumor thrombus is an independent adverse prognostic factor for DFS in ICC patients after radical hepatectomy. Whether the tumor diameter affects survival time after hepatectomy has been controversial. The 6th edition of the AJCC TNM staging system showed that the presence of an isolated lesion or multiple lesions with a diameter ≤ 5 cm indicate a good prognosis. However, the staging system proposed by Okabayashi and Nathan and the 7th edition of the AJCC TNM staging system suggested that tumor diameter is not an independent prognostic factor for postoperative survival time. More recently, there are data to show that size does play a role up to a maximum size of 7 cm and then plateaus. Yamasaki suggested that ICC patients with tumors \> 2 cm in diameter had a relatively poor prognosis \[[@R17]\]. This study has demonstrated that maximum tumor diameter was an independent adverse prognostic factor for survival time after radical resection of ICC. When the maximum tumor diameter increased by one level, the risk of recurrence and death increased 1.330 and 1.326 times, respectively. A study by Nordenstedt showed that gallstones can increase the risk of intrahepatic and extrahepatic cholangiocarcinoma \[[@R18]\]. Mechanisms of intrahepatic bile duct stone formation remain unclear and may be associated with malnutrition, low economic status, and biliary tract infections. Intrahepatic bile duct stones are closely correlated with the incidence of ICC and therefore may be related to the recurrence of ICC after radical resection \[[@R19]-[@R21]\]. In this study, the multivariate analysis showed that complicated bile duct stones are an independent adverse prognostic factor that can affect DFS in patients after radical resection of ICC. The impact of lymph node metastasis on postoperative survival in ICC patients remains debatable. The effect of intraoperative lymphadenectomy during the resection of ICC on prognosis is not yet supported by sufficient data. A study by Shimada et al. showed that intraoperative lymphadenectomy does not improve the prognosis of ICC patients \[[@R22]\]. Studies by Morine et al. have shown that prophylactic lymphadenectomy is not necessary for ICC patients who do not display lymph node metastasis \[[@R23]\]. The study by Li et al. showed that ICC patients without evidence of lymph node metastasis and ICC patients with multiple tumors and lymph node metastasis did not benefit from lymphadenectomy \[[@R24]\]. A systematic review by Amini et al. showed that the 3- and 5-year survival rates were only 0.2 and 0%, respectively, in ICC patients and lymph node metastasis. Although there are not sufficient data to support intraoperative routine lymphadenectomy, lymphadenectomy is recommended during the resection of ICC because of the higher rate of lymph node metastasis in ICC patients \[[@R25]\]. Some studies have shown that lymph node metastasis is an independent prognostic factor for postoperative survival in ICC patients \[[@R26]-[@R28]\]. This study also confirmed that lymph node metastasis was an independent adverse prognostic factor that affects DFS in patients after radical resection of ICC. Terada et al. have reported one case of portal hypertension caused by extensive portal vein tumor thrombi; that patient died of liver function failure 50 days after hospitalization \[[@R29]\]. This study indicated that the macroscopic tumor thrombus was an independent adverse prognostic factor for DFS in patients after undergoing radical resection of ICC. The study by Farges et al. suggested that a satellite lesion was a prognostic factor for OS in patients after undergoing radical resection of ICC; however, these authors were not able to demonstrate that a satellite lesion was an independent prognostic factor for OS in ICC patients \[[@R30]\]. In this group of patients, the postoperative median survival time was 22 months, the 3-year survival rate was 33.9%, and the 5-year survival rate was 23.2%. The 5-year survival rate was higher than that reported by Lang et al., Nathan et al., Jan et al., Ohtsuka et al., and Weimann et al. \[[@R31]-[@R35]\].

In a comparison between the group with OS ≤ 1 year (shorter OS) and the group with OS \> 1 year, the univariate analysis showed that multiple tumors, tumor distribution, complicated bile duct stone, macroscopic tumor thrombus, and lymph node metastasis were possible risk factors for the shorter OS. The studies by Michael et al. revealed that the following factors led to a shorter OS: age, large size of tumor, multiple tumors, lymph node metastasis, vascular invasion, and poorly differentiated tumors \[[@R36]\]. In this study, the univariate analysis indicated that multiple tumors and lymph node metastasis are risk factors for shorter OS. These results are consistent with the findings of Michael et al. In the present study, significant risk factors identified by the univariate analysis were further included in the binary logistic multivariate analysis, which confirmed that macroscopic tumor thrombus may be an independent risk factor for a shorter OS. Studies by Zou et al. have shown that ARID1A, PBRM1, and BAP1, which are tumor suppressor genes, played an important role in suppressing mutations and preventing the occurrence of ICC. The mutation of any single gene in the three wild-type genes can lead to a shorter survival time \[[@R37]\]. This study provided references for further investigating the risk factors of shorter OS after radical resection of ICC.

In summary, radical resection is the only method to potentially cure ICC. However, most patients miss their opportunity for radical surgery because of the late stage of the disease at the time of diagnosis. Even when radical resection is performed, the high recurrence rate and short survival time can negatively affect both the clinicians and ICC patients. In this study, the multi-year follow-up demonstrated that the maximum tumor diameter, complicated bile duct stone, macroscopic tumor thrombus, and lymph node metastasis are independent adverse prognostic factors that can affect survival time in patients who undergo radical resection of ICC. Moreover, risk factors for shorter OS were analyzed. The results showed that macroscopic tumor thrombus is possibly an independent risk factor for mortality within 1 year in patients who undergo radical resection of ICC. The results of this study are intended to guide clinicians in identifying patients with high risks and to give appropriate treatments and interventions as early as possible to improve the life quality and postoperative survival rate of patients.
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